ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Heterogeneity and associated factors of information needs among patients with hematological malignancies in China: a latent profile analysis.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Judicious use of latent profile analysis in supportive care: the distinction between mono- and multi-construct applications.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- Preferences for electronic health information support concerning chemotherapy adverse reactions among young and middle-aged breast cancer patients based on the Kano model.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- Latent profiles of frailty in patients with head and neck cancer undergoing radiotherapy: a cross-sectional study.BMJ open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeHematological malignancies involve complex healthcare situations. Sharing knowledge and providing tailored information based on patients' needs are crucial for patient-centered health care. This study explored information needs among Chinese patients with hematological malignancies and identified factors across distinct subgroups.
methodsWe evaluated 345 patients with hematologic malignancies at any stage from December 2021 to March 2022. Latent profile analysis was used to identify subgroups of hematological malignancy patients with different levels of information needs. Multinomial logistic regression was used to identify factors that were associated with information needs.
resultsThree subgroups of patients with different information needs were identified: low information needs (8.9%), moderate information needs (52.2%), and high information needs (38.8%). Multivariate analysis showed that patients with longer diagnosis time (OR, 0.31; 95% CI, 0.15-0.65), higher quality of life (OR, 0.79; 95% CI, 0.73-0.86), and adequate social support (OR, 0.40; 95% CI, 0.25-0.66) were more likely to be in the low information needs subtypes, whereas patients with worse Eastern Cooperative Oncology Group score (OR, 2.48; 95% CI, 1.00-6.14) were more likely to be in the high information needs subgroup.
conclusionsPatients with hematological malignancies with longer diagnosis time, better quality of life, and adequate social support may be more likely to have low information needs. High information needs may be associated with worse Eastern Cooperative Oncology Group score. Tailored support should be provided to patients based on their information needs. This might help nurses provide relevant support, enhance care quality, and improve patients' quality of life.
Indexed as
Identifiers
40437238What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.